BRIDGE HCV
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Clinical Practice Guideline
Considerations for Antiretroviral Use in Patients With Coinfections: Hepatitis C Virus/HIV Coinfection.
US Department of Health and Human Services (DHHS). Last updated December 2019.
Evaluation and Management of Chronic Hepatitis C Virus (HCV) Infection.
Federal Bureau of Prisons Clinical Guidance. 2018.
HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C.
American Association for the Study of Liver Diseases (AASLD)/Infectious Diseases Society of America (IDSA), Last updated November 2019.
Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force (USPSTF) Recommendation Statement.
USPST. JAMA. 2020;323 (10): 970-975.
Clinical Resources
A Guide to Comprehensive Hepatitis C Counseling and Testing.
Centers for Disease Control and Prevention (CDC).
Harm Reduction Coalition.
HEP Drug Interactions.
University of Liverpool.
PREP-C: Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment.
Mount Sinai School of Medicine.
Rural Health Information Hub.
Action and Advocacy
Appeals letter template for use following HCV treatment denial
Center for Health Law and Policy Innovation (CHLPI)
CHLPI advocates for legal, regulatory, and policy reforms to improve the health of underserved populations. It has played a pivotal role in removing Medicaid restrictions on HCV treatment.
Hepatitis Education Project (HEP)
HEP provides support, education, advocacy, and direct services for people affected by hepatitis, and works to raise hepatitis awareness among patients, medical providers, and the general public.
National Hepatitis Corrections Network (NHCN)
NHCN, managed by HEP, supports a public health approach to hepatitis education, prevention, testing, and treatment in prisons and jails.
National Viral Hepatitis Roundtable
National Viral Hepatitis Roundtable (NVHR) is a coalition working together to eliminate hepatitis B and C in the U.S. It offers practical online resources for practice management.
Substance Abuse and Mental Health Services Administration (SAMHSA): Locator Map
SAMHSA provides an interactive national map that facilitates identification of local resources and services for substance use and mental health disorders.
Patient Resources
Hepatitis C Information Center
The American Liver Foundation’s Hepatitis C Information Center website is a dedicated online information and resource center created in support of individuals impacted by HCV infection.
HepatitisC.net
HepatitisC.net is a website for people living with HCV that offers education, tools, and resources. Articles are written by people living with or cured of HCV, patient advocates, and medical providers.
Hepatitis C Questions and Answers for the Public
Centers for Disease Control and Prevention (CDC). Last reviewed April 2020.The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This patient-directed website addresses basics across the HCV clinical continuum.
The BodyPro — Project Inform
Project Inform promotes the development of effective HIV and HCV therapies; supports patients’ informed choices about their health; advocates for quality, affordable health care; and addresses medical strategies that prevent new infections.
Suggested Readings
“Everybody living with a chronic disease is entitled to be cured”: challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs.
Goodyear T, et al. Int J Drug Policy. 2020;81:102766.
Treatment of HCV in persons who inject drugs: treatment as prevention.
Grebely J, Dore GJ. Clin Liver Dis. 2017;9(4):77-80.
Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: a meta-analysis.
Hajarizadeh B, et al. J Hepatol. 2020;72(4):643-657.
Hepatitis C in pregnancy: a unique opportunity to improve the hepatitis C cascade of care.
Kushner T, Terrault NA. Hepatol Commun. 2019;3(1):20-28.
Clients’ perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.
Masson CL, et al. BMC Infect Dis. 2020;20(1):386.
Opportunities for Current and New HCV Treaters
Relevant Resources
The PCPs Role in Preventing HIV
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis
What Do You Know About PrEP?
Got it? Treat it!
The Critical Role of the Community Pharmacist
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
The Emerging Role of the Diabetologist
Key Issues Impacting OB/GYN Practice
An Interactive Experience Highlighting Recent Clinical Advances
Hot Topics in HBV, HCV, and NASH
Emerging Concepts in Patient Management
Building Your Understanding to Combat a Growing Problem
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Why It Matters in OB/GYN Practice Today
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
How the Pharmacist Can Make a Difference
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Understanding the Growing Syndemic — Opioids, HCV, and HIV
Appraising the Therapeutic Armamentarium in Moderate and Severe Disease
A PrEP Primer
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
The Rapid ART Standard of Care: From Evidence to Healthcare Equity
Maximizing Your Role to Impact Patient Outcomes
Benefits, Barriers, & Best Practices in an Advancing Field
Practical Solutions Across the Spectrum of Care
A PEP/PrEP Training Guide for Pharmacists
An Interactive Learning Experience
